Tenax Laser Resistant Endotracheal Tube
Bryan Medical, Inc. · Decision date Sep 3, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 3, 2026 for K251794, the Tenax® Laser Resistant Endotracheal Tube from Bryan Medical, Inc., under 21 CFR 868.5730 (Tracheal Tube, Class II, product codes BTR and BSK, Anesthesiology panel). SESE is a 510(k) clearance, not a PMA approval. The submission was received June 12, 2025 per the FDA database, while the clearance letter lists a dated and received date of August 4, 2026; the discrepancy is unresolved in the source.
The cleared device is a sterile, single-use endotracheal tube with two inflatable cuffs, an inner aluminum scattering layer for laser resistance, and an internal dye warning indicator. The modification adds 4.0, 4.5 and 8.5 mm sizes to the 5.0–7.5 mm range and makes two material changes across all sizes, relative to the primary predicate K213028 and earlier clearance K200761. The summary states performance testing showed no impact to safety and effectiveness; the underlying test data and the specific material changes are not described in the available excerpts.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Anesthesiology
- Decision date
- Sep 3, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K251794
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Bryan Medical, Inc.
- Product code
- BTR
- Decision code
- SESE
- Decision date
- Sep 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tube, Tracheal (W/Wo Connector).
- Applicant
- Bryan Medical, Inc.
- Product code
- BTR
- FDA device class
- 2
FDA decision timeline
K251794 received
Application receipt date recorded by FDA.
K251794 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bryan Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Cincinnati, OH
Sources and methodology
- Original FDA record: K251794
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records